PreScience Labs

Intellectual Property

PreScience Labs maintains a broad and robust patent portfolio, and has a number of accepted patents and applications pending before domestic and foreign patent agencies. Protection focuses on composition of matter, formulation, therapeutics, and methods of treating cancer using 3-bromopyruvate, other selective inhibitors of ATP production, and delivery mechanisms for administration. PreScience is also seeking protection for use of PSL-001 beyond oncology. Protection focuses on therapeutics for cancer using 3-bromopyruvate, other selective inhibitors of ATP production, methods of administration and formulations. PreScience is also seeking protection for use of PSL-001 beyond oncology.